Showing results (121-130 of 405) with videos related to

Sort By:
Pageof 41
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 29, 2022
Mass drug administration of azithromycin: an analysisRebecca Kahn, Nir Eyal, Samba O Sow, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2006
Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populationsTed Cohen, Marc Lipsitch, Rochelle P Walensky, et al.
Nature Reviews. Immunology|October 7, 2020
Cross-reactive memory T cells and herd immunity to SARS-CoV-2Marc Lipsitch, Yonatan H Grad, Alessandro Sette, et al.
Science (New York, N.Y.)|June 23, 2012
Evolution, safety, and highly pathogenic influenza virusesMarc Lipsitch, Joshua B Plotkin, Lone Simonsen, et al.
Epidemiology (Cambridge, Mass.)|January 22, 2026
Defining and Estimating Outcomes Directly Averted by a Vaccination Program when Rollout Occurs Over TimeKatherine M Jia, Christopher B Boyer, Alyssa Bilinski, et al.
American Journal of Epidemiology|January 26, 2022
Identifying and Alleviating Bias Due to Differential Depletion of Susceptible People in Postmarketing Evaluations of COVID-19 VaccinesRebecca Kahn, Stephanie J Schrag, Jennifer R Verani, et al.
Epidemiology (Cambridge, Mass.)|January 24, 2025
Causal Estimands for Analyses of Averted and Avertible Outcomes due to Infectious Disease InterventionsKatherine M Jia, Christopher B Boyer, Jacco Wallinga, et al.
Nature Communications|December 5, 2013
Real-time influenza forecasts during the 2012-2013 seasonJeffrey Shaman, Alicia Karspeck, Wan Yang, et al.
Pageof 41